CVS

CVS

USD

CVS Health Corporation Common Stock

$78.080-0.360 (-0.459%)

실시간 가격

Healthcare
Healthcare Plans
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$78.440

고가

$79.350

저가

$77.560

거래량

4.28M

기업 기본 정보

시가총액

99.1B

산업

Healthcare Plans

국가

United States

거래 통계

평균 거래량

7.31M

거래소

NYQ

통화

USD

52주 범위

저가 $43.56현재가 $78.080고가 $85.15

관련 뉴스

PR Newswire

CVS Health to hold Investor Day on December 9, 2025

CVS Health® (NYSE: CVS) will hold its Investor Day on December 9th, 2025. Members of management will discuss the Company's strategy and will provide...

더 보기
CVS Health to hold Investor Day on December 9, 2025
Analyst Upgrades

TD Cowen Maintains Buy on CVS Health, Raises Price Target to $100

TD Cowen analyst Charles Rhyee maintains CVS Health with a Buy and raises the price target from $99 to $100.

더 보기
TD Cowen Maintains Buy on CVS Health, Raises Price Target to $100
Reuters

Obamacare premiums double, adding post Halloween fright for US health insurance shoppers

Americans shopping for 2026 Obamacare health insurance plans are facing a more than doubling of monthly premiums on average and are likely to postpone signing up in hopes of a last-minute reprieve, or walk away, health experts say.

더 보기
Obamacare premiums double, adding post Halloween fright for US health insurance shoppers
PR Newswire

CVS Health Boosts CVS Pharmacy Customer Generosity to Address Food Insecurity

CVS Pharmacy® customers donated more than $3 million this year to support local food banks across the country, and CVS Health® (NYSE: CVS) is...

더 보기
CVS Health Boosts CVS Pharmacy Customer Generosity to Address Food Insecurity
Analyst Upgrades

Evercore ISI Group Maintains Outperform on CVS Health, Raises Price Target to $95

Evercore ISI Group analyst Elizabeth Anderson maintains CVS Health with a Outperform and raises the price target from $85 to $95.

더 보기
Evercore ISI Group Maintains Outperform on CVS Health, Raises Price Target to $95
Analyst Upgrades

RBC Capital Maintains Outperform on CVS Health, Raises Price Target to $93

RBC Capital analyst Ben Hendrix maintains CVS Health with a Outperform and raises the price target from $81 to $93.

Analyst Upgrades

Cantor Fitzgerald Maintains Overweight on CVS Health, Raises Price Target to $95

Cantor Fitzgerald analyst Sarah James maintains CVS Health with a Overweight and raises the price target from $78 to $95.